Dr. Oh is a medical oncologist who cares for patients who are receiving novel immunotherapies for cancers as part of clinical trials. These are treatments that harness the patient’s own immune system to fight cancer. He specializes in prostate and bladder cancers. Dr. Oh’s research focuses on understanding and improving cancer immunotherapies. He leads clinical trials to evaluate new immunotherapies for solid tumors, and he studies samples from patients who have received immunotherapies with the goal of better understanding their benefits and side effects.

Dr. Oh earned his medical degree from Stanford University School of Medicine, where he also completed a doctorate in physiology. At UCSF, he completed a residency in internal medicine and a fellowship in hematology and oncology.

Dr. Oh is a member of the American Society of Clinical Oncology, American Association for Cancer Research and Society for Immunotherapy of Cancer. He has received Young Investigator Awards from the Prostate Cancer Foundation, Bladder Cancer Advocacy Network and Conquer Cancer Foundation of the American Society of Clinical Oncology.